Danuglipron is a small-molecule GLP-1 receptor agonist that was under development as an oral pharmaceutical compound. It has been investigated for its effects on weight reduction and glycemic control, with nausea, diarrhea, and vomiting reported as common adverse events.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing Danuglipron?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
3-Methylclobazam
pharmaceutical raw material
Clobazam impurity A CRS
pharmaceutical raw material
Clobazam
pharmaceutical raw material
Norclobazam
pharmaceutical raw material
The international HS code for Danuglipron (CAS 2230198-02-2) is 2934.99.
2934.99
2934 99 90
Classification per the EU customs inventory ECICS (2026-07 snapshot, HS 2022). National tariff lines and product form can affect the final classification.
2-[[4-[6-[(4-cyano-2-fluorophenyl)methoxy]-2-pyridinyl]piperidin-1-yl]methyl]-3-[[(2S)-oxetan-2-yl]methyl]benzimidazole-5-carboxylic acid
HYBAKUMPISVZQP-DEOSSOPVSA-N
C1CO[C@@H]1CN2C3=C(C=CC(=C3)C(=O)O)N=C2CN4CCC(CC4)C5=NC(=CC=C5)OCC6=C(C=C(C=C6)C#N)F
Sourcing Danuglipron?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.